Prediction Case File
YouTubeEvaluation Complete

Friends! In this video, I'm going to do an Amazon stock analysis and talk about the risks and upside potential of AMZN stock.

1 extracted signal · 1 resolved · 0 still active

The Patient Investor profile imageThe Patient Investor04 Aug 2025, 17:44 UTC
Video preview for Friends! In this video, I'm going to do an Amazon stock analysis and talk about the risks and upside potential of AMZN stock.
Signals
1
Eligible signals in this source
Open
0
Still being tracked
Resolved
1
Evaluable outcomes
Successful
1
Canonical correct result
Failed
0
Canonical failed result
Resolved success
100%
Open and excluded signals omitted
Source overview

AI-generated source summary

The analyst reviews Amazon's Q2 2025 earnings report, noting an earnings per share of $1.68 versus the estimated $1.33 and revenue of $167.7 billion versus the estimated $162.09 billion. Amazon Web Services revenue grew 18%, trailing Microsoft Azure and Google Cloud. The advertising revenue grew 23% year-over-year. Guidance for the third quarter is set at $174 billion to $179.5 billion. The analyst notes that the stock went down 8.5% on the day and explores the decrease in the growth of cash flow from operations. After looking at a forward price to operating cash flow which at is at 14.2, analyst infers Amazon is still undervalued and infers a target of $250, setting a fail bound below $190, monitoring the future results.

AI-generated summary based on the source content.

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. First prediction resolved

    The first evaluable outcome in this case reached a terminal result.

  3. Case evaluation completed

    All evaluable predictions in this case reached terminal outcomes.

  4. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  5. Market predictions extracted

    1 eligible signal linked to this case.

  6. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

Extracted intelligence

Signals in this source

Continue the evidence trail
Analyst history

The Patient Investor

Tracked signals
292
Historical success
32.9%
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.